Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 34% ± 12% | |
peripheral blood | 20 studies | 44% ± 14% | |
brain | 13 studies | 30% ± 13% | |
intestine | 10 studies | 27% ± 9% | |
kidney | 8 studies | 29% ± 11% | |
bone marrow | 5 studies | 36% ± 15% | |
lymph node | 5 studies | 41% ± 11% | |
liver | 5 studies | 43% ± 20% | |
uterus | 4 studies | 39% ± 14% | |
breast | 4 studies | 29% ± 4% | |
adipose | 4 studies | 25% ± 9% | |
pancreas | 3 studies | 44% ± 9% | |
placenta | 3 studies | 39% ± 7% | |
eye | 3 studies | 29% ± 9% | |
heart | 3 studies | 20% ± 1% | |
prostate | 3 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10790.35 | 1445 / 1445 | 100% | 93.17 | 183 / 183 |
intestine | 100% | 8600.69 | 966 / 966 | 100% | 72.49 | 527 / 527 |
ovary | 100% | 4833.20 | 180 / 180 | 100% | 62.77 | 430 / 430 |
stomach | 100% | 5998.98 | 359 / 359 | 100% | 70.98 | 286 / 286 |
breast | 100% | 7616.22 | 459 / 459 | 100% | 69.70 | 1117 / 1118 |
lung | 100% | 9634.30 | 577 / 578 | 100% | 86.74 | 1155 / 1155 |
bladder | 100% | 8545.57 | 21 / 21 | 100% | 65.60 | 503 / 504 |
uterus | 100% | 7989.92 | 170 / 170 | 100% | 70.17 | 458 / 459 |
thymus | 100% | 5503.46 | 652 / 653 | 100% | 42.42 | 602 / 605 |
prostate | 100% | 5777.93 | 244 / 245 | 99% | 42.02 | 497 / 502 |
brain | 98% | 4630.38 | 2597 / 2642 | 100% | 45.06 | 705 / 705 |
kidney | 100% | 5719.51 | 89 / 89 | 98% | 51.01 | 879 / 901 |
skin | 100% | 11639.71 | 1808 / 1809 | 97% | 62.42 | 460 / 472 |
adrenal gland | 100% | 11697.26 | 258 / 258 | 95% | 34.59 | 218 / 230 |
pancreas | 90% | 2904.76 | 296 / 328 | 99% | 61.79 | 176 / 178 |
liver | 93% | 2971.88 | 211 / 226 | 89% | 24.90 | 363 / 406 |
adipose | 100% | 8977.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11371.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 127.39 | 29 / 29 |
spleen | 100% | 10378.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 74.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.24 | 1 / 1 |
peripheral blood | 99% | 18381.07 | 922 / 929 | 0% | 0 | 0 / 0 |
muscle | 95% | 3081.83 | 766 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 4509.30 | 800 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 23.30 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033206 | Biological process | meiotic cytokinesis |
GO_0060271 | Biological process | cilium assembly |
GO_0070358 | Biological process | actin polymerization-dependent cell motility |
GO_0016344 | Biological process | meiotic chromosome movement towards spindle pole |
GO_0008356 | Biological process | asymmetric cell division |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_0051653 | Biological process | spindle localization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0005903 | Cellular component | brush border |
GO_0005885 | Cellular component | Arp2/3 protein complex |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0005911 | Cellular component | cell-cell junction |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACTR3 |
Protein name | Actin-related protein 3 (Actin-like protein 3) Actin related protein 3 |
Synonyms | ARP3 |
Description | FUNCTION: ATP-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) . The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility . Seems to contact the pointed end of the daughter actin filament . In podocytes, required for the formation of lamellipodia downstream of AVIL and PLCE1 regulation . In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA . The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) . Plays a role in ciliogenesis . . |
Accessions | F8WE84 P61158 ENST00000443297.5 ENST00000263238.7 ENST00000446821.5 F8WEW2 ENST00000415792.5 F8WDR7 B4DXW1 ENST00000535589.3 |